Hat glasses for eye protection during jaundice light therapy
Part of Genetic & congenital clinical trials.
This trial tests a special hat-like glasses to protect babies' eyes during phototherapy (light treatment for jaundice). It is for healthy full-term newborns who are in a regular hospital room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be a full-term newborn (born between 38 and 42 weeks).
- Your baby's Apgar score at birth must be 7, 8, 9, or 10 (a healthy score).
- Your baby must be staying in a regular hospital room and in a standard crib.
- Your baby cannot have a serious (pathological) form of jaundice.
- Your baby must not have any birth defects or congenital anomalies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
This trial tests a scoring tool called BIND to see how well it predicts which newborns with severe jaundice need intensive treatment. If you have a baby under 28 days old with severe jaundice that might need a blood transfusion, this study could apply to them.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.